A Simple Paper-Based, Wearable Device for Long Term Sweat Analysis
|
By LabMedica International staff writers Posted on 16 Jun 2020 |

Image: The evaporation of sweat on paper pads could be used for fluid transport in a wearable device over long periods of time. The resulting dry layer of caked salts would preserve a `time-stamped` record of biomarkers of interest (Photo courtesy of Dr. Orlin D. Velev and co-authors, North Carolina State University)
By cleverly manipulating paper geometry, researchers created a paper-based wearable device to collect, transport, and analyze sweat for an extended period.
Sweat can be used to obtain an exact measurement of concentrations of medications in the blood. Furthermore, the concentrations of stress biomarkers (hormones and neurotransmitters) in bodily fluids such as sweat predict the physical and mental state of the individual.
A major problem that has so far restricted the use of wearable paper-based sweat sensors is that sweat contains salt, which, upon evaporation, becomes deposited on the device and interferes with fluid flow. To solve this problem, investigators at North Carolina State University (Raleigh, USA) characterized and analyzed how capillary action and evaporation could cooperatively be used to transport and process a sweat-like fluid containing dissolved salts and model analytes.
The investigators postulated that the joint action of capillary wicking and evaporation would sustain continuous and long-term withdrawal of the sweat-like fluid. In the laboratory they then demonstrated that paper strips of controlled geometry could passively pump fluid for sensing purposes for long duration. Thus, non-invasive osmotic extraction combined with paper microfluidics and evaporative disposal enabled sweat collection and monitoring for periods exceeding 10 days. Since the process was driven by the liquid wicking through paper, the device did not require an external power source.
The investigators also demonstrated that the salt film deposited at the evaporation pad would eventually lead to cessation of the process but at the same time would preserve a record of analytes that could be used for long-term biomarker monitoring in sweat.
"We expected that the flow of the model sweat will be suppressed by the deposition of a salt layer inside the drying pad," said senior author Dr. Orlin Velev, professor of chemical and biomolecular engineering at North Carolina State University. "By following the flow of model sweat, we found, quite surprisingly, that such a simple paper construct can achieve continuous sweat pumping and disposal for very long periods."
The wearable device for sweat analysis was described in the June 9, 2020, online edition of the journal Biomicrofluidics.
Related Links:
North Carolina State University
Sweat can be used to obtain an exact measurement of concentrations of medications in the blood. Furthermore, the concentrations of stress biomarkers (hormones and neurotransmitters) in bodily fluids such as sweat predict the physical and mental state of the individual.
A major problem that has so far restricted the use of wearable paper-based sweat sensors is that sweat contains salt, which, upon evaporation, becomes deposited on the device and interferes with fluid flow. To solve this problem, investigators at North Carolina State University (Raleigh, USA) characterized and analyzed how capillary action and evaporation could cooperatively be used to transport and process a sweat-like fluid containing dissolved salts and model analytes.
The investigators postulated that the joint action of capillary wicking and evaporation would sustain continuous and long-term withdrawal of the sweat-like fluid. In the laboratory they then demonstrated that paper strips of controlled geometry could passively pump fluid for sensing purposes for long duration. Thus, non-invasive osmotic extraction combined with paper microfluidics and evaporative disposal enabled sweat collection and monitoring for periods exceeding 10 days. Since the process was driven by the liquid wicking through paper, the device did not require an external power source.
The investigators also demonstrated that the salt film deposited at the evaporation pad would eventually lead to cessation of the process but at the same time would preserve a record of analytes that could be used for long-term biomarker monitoring in sweat.
"We expected that the flow of the model sweat will be suppressed by the deposition of a salt layer inside the drying pad," said senior author Dr. Orlin Velev, professor of chemical and biomolecular engineering at North Carolina State University. "By following the flow of model sweat, we found, quite surprisingly, that such a simple paper construct can achieve continuous sweat pumping and disposal for very long periods."
The wearable device for sweat analysis was described in the June 9, 2020, online edition of the journal Biomicrofluidics.
Related Links:
North Carolina State University
Latest Molecular Diagnostics News
- Plasma ctDNA Testing Predicts Breast Cancer Recurrence After Neoadjuvant Therapy
- New Respiratory Panel Expands Pathogen Detection to 25 Targets
- Simple Nasal Swab May Reveal Early Signs of Alzheimer’s Disease
- Blood Biomarker Predicts Cognitive Outcomes After Cardiac Arrest
- Liquid Biopsy Enables Faster Diagnosis of Childhood Cancer in Africa
- Blood Test Helps Guide Treatment in Older Women with Breast Cancer
- Rapid Host-Response Test Distinguishes Bacterial and Viral Infections in Minutes
- Liquid Biopsy Method Pinpoints Disease Source From a Single Drop of Blood
- Study Reveals Widespread Errors in Gene Variant Naming
- New Blood Test Aims to Transform Liver Cancer Surveillance
- New Biomarkers Indicate Higher Liver Cancer Risk in Chronic Hepatitis B Patients
- Precision Analyzer Reveals ‘Chameleon Proteins’ Causing Intractable Diseases
- Alzheimer's Blood Marker Could Improve Detection of Heart and Kidney Diseases
- Single Blood Test Predicts Heart Diseases 15 Years Before Onset
- Blood Immune 'Fingerprint' Predicts Side Effects of New Alzheimer's Drug
- Clinical Diagnostic Test Detects Additional Genetic Variants in Acute Leukemia Patients
Channels
Clinical Chemistry
view channel
Blood-Based Screening Test Targets Early Detection of Colorectal Cancer
Colorectal cancer (CRC) is a leading cause of cancer-related death worldwide, with more than 60% of cases still diagnosed at a late stage. Uptake of existing screening tools remains suboptimal,... Read more
Automated NfL Assay Supports Monitoring of Neurological Disorders
Neuroaxonal injury occurs across a wide range of neurological disorders and remains difficult to monitor noninvasively over time. Blood-based measurement of neurofilament light chain (NfL) provides a biologically... Read moreHematology
view channel
Rapid Cartridge-Based Test Aims to Expand Access to Hemoglobin Disorder Diagnosis
Sickle cell disease and beta thalassemia are hemoglobin disorders that often require referral to specialized laboratories for definitive diagnosis, delaying results for patients and clinicians.... Read more
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read moreImmunology
view channel
Study Identifies Inflammatory Pathway Driving Immunotherapy Resistance in Bladder Cancer
Bladder cancer remains a prevalent malignancy with variable responses to immune checkpoint inhibitors. Clinicians often observe elevated C-reactive protein and interleukin-6 in affected patients, yet the... Read more
Microfluidic Chip Detects Cancer Recurrence from Immune Response Signals
Early identification of treatment response and relapse remains a major challenge in solid tumors, where minimal residual disease is difficult to detect with routine imaging and blood tests.... Read moreMicrobiology
view channel
Breath Analysis Approach Offers Rapid Detection of Bacterial Infection
Accurate and rapid identification of bacterial infections remains challenging in acute care, where delays can hinder timely, targeted therapy. Infectious diseases are a major cause of mortality worldwide,... Read more
Study Highlights Accuracy Gaps in Consumer Gut Microbiome Kits
Direct-to-consumer gut microbiome kits promise personalized insights by profiling fecal bacteria and generating health readouts, but their analytical accuracy remains uncertain. A new study shows that... Read more
WHO Recommends Near POC Tests, Tongue Swabs and Sputum Pooling for TB Diagnosis
Tuberculosis (TB) remains one of the world’s leading infectious disease killers, yet millions of cases go undiagnosed or are detected too late. Barriers such as reliance on sputum samples, limited laboratory... Read morePathology
view channel
Biopsy-Based Gene Test Predicts Recurrence Risk in Lung Adenocarcinoma
Lung cancer is the leading cause of cancer death, killing more people in the United States than breast, prostate, and colon cancers combined. In lung adenocarcinoma (LUAD), tumors that invade nearby blood... Read more
AI-Powered Tool to Transform Dermatopathology Workflow
Skin cancer accounts for the largest number of cancer diagnoses in the United States, placing sustained pressure on pathology services. Diagnostic interpretation can be variable for challenging melanocytic... Read moreTechnology
view channel
Online Tool Supports Family Screening for Inherited Cancer Risk
Genetic test results in oncology often have implications for relatives who may share inherited cancer risk. Many health systems lack structured processes to help patients alert family members, limiting... Read more
Portable Breath Sensor Detects Pneumonia Biomarkers in Minutes
Pneumonia is commonly confirmed with chest X-rays or laboratory assays that can take hours, delaying clinical decisions in acute and outpatient settings. Breath-based diagnostics promise faster answers... Read moreIndustry
view channel
Integrated DNA Technologies Expands into Clinical Diagnostics
Integrated DNA Technologies (IDT; Coralville, Iowa, USA) has announced the launch of Archer FUSIONPlex-HT Dx and VARIANTPlex-HT Dx. This launch marks the company’s first in vitro diagnostic (IVD) offerings... Read more




.jpg)



